BP003134: Human HLA-A*02:01&B2M&MAGE-A10 (GLYDGMEHL) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*02:01&B2M&MAGE-A10 (GLYDGMEHL) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and GLYDGMEHL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.PA007176: In Vivo Grade Recombinant Anti-HIV gp120-gp41 Interface Human IgG1 Lambda Monoclonal Antibody
The in vivo grade recombinant anti-HIV gp120-gp41 interface human IgG1 monoclonal antibody (clone of PGT152) was produced in mammalian cells.
Applications: ELISA, Western blot, immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.C104P: Dupilumab Biosimilar, IL4R alpha Monoclonal Antibody
Recombinant fully human IgG4 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody dupilumab biosimilar specifically binds to the human IL4R alpha.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by dupilumab.C105P: Evolocumab Biosimilar, PCSK9 Monoclonal Antibody
Recombinant fully human IgG2 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody evolocumab biosimilar specifically binds to the human PCSK9.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by evolocumab.C106P: Ifinatamab Biosimilar, B7-H3 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade ifinatamab biosimilar specifically binds to the human B7-H3 (CD276) protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ifinatamab.C109P: Tusamitamab Biosimilar, CEACAM5 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade tusamitamab biosimilar specifically binds to the CEACAM5 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tusamitamab.C108P: Rovalpituzumab Biosimilar, DLL3 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade rovalpituzumab biosimilar specifically binds to the DLL3 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by rovalpituzumab.C110P: Tanezumab Biosimilar, NGF Monoclonal Antibody
Recombinant Humanized IgG2 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade tanezumab biosimilar specifically binds to the NGF protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tanezumab.C107P: Cofetuzumab Biosimilar, PTK7 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade cofetuzumab biosimilar specifically binds to the PTK7 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by cofetuzumab.PA000080-MA1060: P-Glycoprotein Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: WB, IHC-P, IHC-F, ICC;
Reactivity: Human;
Clone: PG-13;
Isotype: Mouse IgG1.